Welcome to the OBI,
EndoRel Biosciences!
EndoRel Biosciences is developing a novel endosomal release platform for targeted intracellular delivery. Their focus is on cytosolic delivery of RNA therapeutics and therapeutic antibodies or antibody fragments. They work closely with collaborators and customers to improve drug efficacy and safety through better intracellular delivery.
EndoRel is moving into the brand new lab and office in Suite 200 this month. Congratulations to them on their new space!
OBI Client Company Recent Wins
- We were awarded a grant from Oregon Health & Science University’s new Oregon Clinical and Translational Institute (OCTRI) Regulatory Consultation and Assistance Program to help fund the development of an FDA 510(k) application for the use of our GPF diagnostic test in cardiovascular disease risk assessment.
- Our latest paper showing world record-high GPF levels in COVID-19 patients is now online.
- Submitted the NIH SBIR Phase1 grant proposal titled “Volume Electron Microscopy Vision Systems for Tumor Biopsy Analysis”. This is a collaboration between HTI and OHSU/KCI with strong endorsement and letter of support (LOS) from Dr. Gordon Mills, Dr. Joe Gray, Dr. Xubo Song & Jessica Riesterer. Also, received LOS from Thermo Fisher and the Business Oregon Phase 0 matching grant. Volume electron microscopy (vEM) is a rapidly developing technology that holds the promise of determining the structure of cells and their interactions at nanometer scale.
- HTI’s CryoFAST ™, an AI based Autonomous cryo-EM data collection, presented by PNCC at the NIH conference with great support from cryo-EM users.
- CryoFAST’s GTM (go-to-market) product plan being defined with two major channels, including pricing and launch timeline.
- HTI will join the Oregon BIO pavilion at the BIO24 conference on June 3-6 in San Diego, partnering planning in full swing.
- Connor Barth, PhD and Trace Bio won the FastPitch Judge’s Award and a $5000 prize at Life Science Innovation Northwest in April!
- See Connor and his big check in OHSU Innovates’ LinkedIn post.
- ESG Brands was named one of 35 U.S. Startups to Watch in the Chicago Business Journal.
- Vivifi Medical is making great progress in BPH and early-stage prostate cancer surgery. Read their press release.
Sparrow Pharmaceuticals (OBI alumnus)
- Big news for Sparrow: They recently raised $10.2 million for clinical trials for a drug therapy for treat endocrine disorders caused by excess cortisol. Congratulations!
Learn more about OBI’s 32 startups by visiting our website!
GAFC Stage One Winners Announced
Oregon Health & Science University’s OCTRI has been named a winner in Stage One of the SBA’s 2024 Growth Accelerator Fund Competition in the Sustainability and Biotechnology category! This prestigious award recognizes OCTRI and Ecosystem Partners’ outstanding efforts in ecosystem building, including the recruitment of new partners and strengthening of existing alliances for a Biotechnology Collective, facilitating biotechnology advances to support undercapitalized entrepreneurs in this sector.
Oregon Bioscience Incubator/OTRADI is a proud Ecosystem Partner and contributor on this Stage One submission, along with Oregon Bioscience Association. We look forward to submitting our Stage Two proposal in June with additional Ecosystem Partners and a robust network to support startups.
We also want to congratulate VertueLab for winning a GAFC Stage One award as well, for their Just Climate Tech Transition program. What a way to represent Oregon and the Pacific Northwest!
Read about OHSU’s submission on line 35. and VertueLab’s submission on line 58.
University Summer Investment Opportunity
Deadline May 10
Don’t miss your chance to apply for the University Summer Investment Opportunity by May 10 at midnight. If your startup has IP licensed from Oregon Health & Science University, University of Oregon, Portland State University, or Oregon State University, apply now!
All the details and links are here.
Business Oregon Invests in Oregon Startups
Business Oregon recently announced a $6.5 million investment through its SSBCI Business Oregon Venture Fund (BOV) Program. The Oregon Venture Fund received $6 million and the Oregon Nanoscience and Microtechnologies Institute (ONAMI) received $500,000 to invest in Oregon startups.
Read more details about this investment and how $6.5 million will result in $15 million in total investments!
Pre-College Summer Institute at George Fox University
Dates: June 23 – 28
High school students are invited to experience college living and learning at George Fox this summer – and earn college credit in a week-long, immersive biotechnology institute.
Students will learn the basics of biotechnology and explore where this technology will take us. Then, they’ll head into the laboratory to test agricultural products for genetic modification and use CRISPR technology to modify the genome of E. coli to produce an effect visible to the naked eye.
All OBI-members are provided a $500 discount on registration, as thanks for the long-standing partnership between OBI and George Fox. Use Code: OBI2024
Learn more and register for the Pre-College Summer Institute at: https://www.georgefox.edu/early-college/summer-programs/biotechnology.html
Upcoming Events at OBI
Thermo Fisher Scientific Office Hours
May 16, 2024 | 11:00 a.m. – 2:00 p.m.
OBI Event Space, Portland
Stop by to say hi!
Lunch & Learn with Moss Adams:
R&D Tax Credit – Does Your Company Qualify?
May 22, 2024 | 12:00-1:00 p.m.
OBI Event Space -OR- Virtual
Free to attend – register in advance
Workshop with Travis Rappleye:
MedTech Product Development 101
June 4, 2024 | 1:00-4:00 p.m.
OBI Suite 200 Conference Room
Details and registration
Startup Spotlight Expo:
Featuring the Innovative Startups within OBI
September 12, 2024 | 5:00-8:00 p.m.
OBI Event Space, Portland
Tickets on sale now
Other Community Events
OHSU Innovation Day
May 9 | 10:00 a.m.-2:00 p.m. and 4:00-5:00 p.m.
Virtual for daytime sessions
Late afternoon at OHSU Auditorium, Portland
Free to attend – registration
University Lab Partners Hybrid Lunch & Learn:
How to Get a Term Sheet in Today’s Investment Climate
May 14, 2024 | 12:00-1:00 p.m.
Virtual -OR- In-Person in Irvine, CA
Registration
University Lab Partners SBIR/STTR Series
May 22, June 5, and June 12, 2024 | 9:00-10:00 a.m.
Virtual
Registration